Rognan, D.

Ranking Targets in Structure-Based Virtual Screening of Three-Dimensional Protein Libraries: Methods and Problems

Structure-based virtual screening is a promising tool to identify putative targets for a specific ligand.

Kellenberger, E.

Molecular modeling of the second extracellular loop of G-protein coupled receptors and its implication on structure-based virtual screening

The current study describes the validation of high-throughput modeling procedures for the construction of the second extracellular loop (ecl2) of all nonolfactory human G …

Graaf, C.

How to measure the similarity between protein ligand-binding sites?

Quantification of local similarity between protein 3D structures is a promising tool in computer-aided drug design and prediction of biological function.

Kellenberger, E.

A simple and fuzzy method to align and compare druggable ligand-binding sites

A novel method to measure distances between druggable protein cavities is presented.

Schalon, C.

Identification of Nonpeptide CCR5 Receptor Agonists by Structure-based Virtual Screening

A three-dimensional model of the chemokine receptor CCR5 has been built to fulfill structural peculiarities of its α-helix bundle and to distinguish known CCR5 antagonists from …

Kellenberger, E.

Topological analysis of the complex formed between neurokinin A and the NK2 tachykinin receptor

Neurokinin A stimulates physiological responses in the peripheral and central nervous systems upon interacting primarily with the tachykinin NK2 receptor (NK2R).

Zoffmann, S.

Optimizing Fragment and Scaffold Docking by Use of Molecular Interaction Fingerprints

Protein−ligand interaction fingerprints have been used to postprocess docking poses of three ligand data sets:  a set of 40 low-molecular-weight compounds from the Protein Data …

Marcou, G.

Chemogenomic approaches to rational drug design

Paradigms in drug design and discovery are changing at a significant pace.

Rognan, D.